Aspira Women's Health Inc. (AWH) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
12117 BEE CAVES ROAD BUILDING THREE AUSTIN, TX 78738 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 37,180 | 5,539 | 5,242 | 18,642 | |||||
| Cash and cash equivalents | 37,180 | 5,539 | 5,242 | 18,642 | |||||
| Receivables | 1,027 | 865 | 924 | 786 | 205 | 275 | 87 | ||
| Inventory, net of allowances, customer advances and progress billings | 174 | 30 | 25 | 92 | 102 | 93 | 87 | ||
| Inventory | 174 | 30 | 25 | 92 | 102 | 93 | 87 | ||
| Other undisclosed current assets | 1,624 | 17,708 | 12,461 | 9,910 | 459 | 498 | 550 | ||
| Total current assets: | 40,005 | 18,603 | 13,410 | 10,788 | 6,305 | 6,108 | 19,366 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 346 | 406 | ✕ | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 464 | 583 | 353 | 608 | 1,181 | 1,911 | 1,504 | ||
| Restricted cash and investments | 250 | ||||||||
| Other noncurrent assets | 14 | 13 | 65 | 12 | 11 | ||||
| Other undisclosed noncurrent assets | 90 | ||||||||
| Total noncurrent assets: | 1,074 | 1,002 | 418 | 620 | 1,192 | 1,911 | 1,594 | ||
| TOTAL ASSETS: | 41,079 | 19,605 | 13,828 | 11,408 | 7,497 | 8,019 | 20,960 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 6,800 | 4,767 | 3,746 | 2,775 | 2,395 | 2,345 | 3,196 | ||
| Accounts payable | 1,501 | 1,149 | 1,158 | 950 | 745 | 881 | 988 | ||
| Accrued liabilities | 5,299 | 3,618 | 2,588 | 1,825 | 1,650 | 1,464 | 2,208 | ||
| Debt | 980 | 1,610 | 193 | 189 | 185 | 182 | |||
| Other liabilities | 39 | 29 | 34 | 155 | |||||
| Other undisclosed current liabilities | 60 | 23 | |||||||
| Total current liabilities: | 7,840 | 6,400 | 3,978 | 2,964 | 2,609 | 2,561 | 3,351 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 3,067 | 3,486 | 1,099 | 1,292 | 1,481 | 1,667 | 63 | ||
| Long-term debt, excluding current maturities | 2,718 | 3,077 | 1,099 | 1,292 | 1,481 | 1,667 | |||
| Capital lease obligations | ✕ | ✕ | ✕ | 63 | |||||
| Operating lease, liability | 349 | 409 | ✕ | ✕ | ✕ | ✕ | |||
| Liabilities, other than long-term debt | 13 | 29 | |||||||
| Other liabilities | 13 | 29 | |||||||
| Other undisclosed noncurrent liabilities | (349) | (409) | |||||||
| Total noncurrent liabilities: | 3,067 | 3,486 | 1,112 | 1,292 | 1,481 | 1,696 | 63 | ||
| Total liabilities: | 10,907 | 9,886 | 5,090 | 4,256 | 4,090 | 4,257 | 3,414 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 30,172 | 9,719 | 8,738 | 7,152 | 3,407 | 3,762 | 17,546 | ||
| Common stock | 112 | 105 | 97 | 75 | 60 | 52 | 52 | ||
| Additional paid in capital | 501,788 | 449,680 | 430,802 | 414,001 | 399,400 | 389,266 | 388,082 | ||
| Accumulated deficit | (471,728) | (440,066) | (422,161) | (406,924) | (396,053) | (385,556) | (370,588) | ||
| Total stockholders' equity: | 30,172 | 9,719 | 8,738 | 7,152 | 3,407 | 3,762 | 17,546 | ||
| TOTAL LIABILITIES AND EQUITY: | 41,079 | 19,605 | 13,828 | 11,408 | 7,497 | 8,019 | 20,960 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 6,812 | 4,651 | 4,538 | 3,053 | 3,121 | 2,642 | 2,177 | |
| Revenue, net | ✕ | ✕ | ✕ | ✕ | 3,121 | 2,642 | 2,177 | |
| Cost of revenue (Cost of Goods and Services Sold) | (3,750) | (3,415) | (3,343) | (3,142) | (2,914) | (2,698) | (2,309) | |
| Gross profit: | 3,062 | 1,236 | 1,195 | (89) | 207 | (56) | (132) | |
| Operating expenses | (35,657) | (19,217) | (16,473) | (11,244) | (10,648) | (14,898) | (19,117) | |
| Operating loss: | (32,595) | (17,981) | (15,278) | (11,333) | (10,441) | (14,954) | (19,249) | |
| Nonoperating income (expense) | 981 | 66 | (18) | (16) | (14) | 14 | 106 | |
| Investment income, nonoperating | 28 | |||||||
| Other nonoperating income (expense) | 981 | 66 | (18) | (16) | (14) | |||
| Interest and debt expense | 37 | |||||||
| Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | 35,820 | (9) | ||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (31,614) | 17,905 | (15,296) | (11,349) | (10,455) | (14,940) | (19,115) | |
| Other undisclosed income from continuing operations before income taxes | 63,276 | |||||||
| Net income (loss): | 31,662 | 17,905 | (15,296) | (11,349) | (10,455) | (14,940) | (19,115) | |
| Other undisclosed net income (loss) attributable to parent | (63,324) | (35,810) | 59 | (22) | (42) | (28) | ||
| Net loss attributable to parent: | (31,662) | (17,905) | (15,237) | (11,371) | (10,497) | (14,968) | (19,115) | |
| Undistributed earnings (loss) allocated to participating securities, basic | (942) | ✕ | ✕ | |||||
| Net loss available to common stockholders, diluted: | (31,662) | (17,905) | (15,237) | (11,371) | (11,439) | (14,968) | (19,115) | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 31,662 | 17,905 | (15,296) | (11,349) | (10,455) | (14,940) | (19,115) | |
| Comprehensive income (loss), net of tax, attributable to parent: | 31,662 | 17,905 | (15,296) | (11,349) | (10,455) | (14,940) | (19,115) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.